RxSight, Inc. Balance Sheet
RXST|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
RxSight, Inc. had $312M in total assets and $276M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $19.9M | $16.7M | $9.7M | $11.8M | $24.4M |
| Accounts Receivable | $23.4M | $30.1M | $20.3M | $11.0M | $4.9M |
| Inventory | $31.6M | $22.0M | $17.4M | $14.8M | $8.0M |
| Current Assets | $287.5M | $293.8M | $168.4M | $134.6M | $176.3M |
| PP&E (Net) | $13.1M | $12.4M | $10.8M | $10.1M | $11.2M |
| Total Assets | $311.8M | $318.6M | $182.6M | $150.2M | $192.7M |
| Current Liabilities | $26.3M | $25.9M | $20.9M | $17.2M | $11.1M |
| Total Debt | - | - | - | $40.2M | $39.8M |
| Shareholders' Equity | $275.7M | $281.2M | $160.4M | $89.9M | $138.2M |